These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6127383)

  • 1. A study of the effects of nabumetone (BRL 14777), a novel anti-inflammatory drug, on cell infiltration into sterile cotton pellets implanted in rats.
    Freeman PC; Mangan FR; Watkins DK
    J Pharm Pharmacol; 1982 Sep; 34(9):580-3. PubMed ID: 6127383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of nabumetone into inflammatory exudates in the rat.
    Haddock RE; Jeffery DJ; Mangan FR; Pardon IS
    J Pharm Pharmacol; 1983 Jun; 35(6):358-62. PubMed ID: 6135773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a novel, non-steroidal anti-inflammatory compound, nabumetone (BRL 14777), on cellular infiltration into 24-hour polyvinyl sponge implants in the rat, compared with some steroidal and non-steroidal anti-inflammatory drugs.
    Boyle EA; Mangan FR
    J Pharm Pharmacol; 1982 Sep; 34(9):570-5. PubMed ID: 6127381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammation.
    Salmon JA; Simmons PM; Moncada S
    J Pharm Pharmacol; 1983 Dec; 35(12):808-13. PubMed ID: 6141244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nabumetone (BRL 14777, 4-[6-methoxy-2-naphthyl]-butan-2-one): a new anti-inflammatory agent.
    Boyle EA; Freeman PC; Mangan FR; Thomson MJ
    J Pharm Pharmacol; 1982 Sep; 34(9):562-9. PubMed ID: 6127380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on cell motility in inflammation. II. The in vivo effect of anti-inflammatory and anti-rheumatic drugs on chemotaxis in vitro.
    Parente L; Koh MS; Willoughby DA; Kitchen A
    Agents Actions; 1979 Jun; 9(2):196-200. PubMed ID: 314231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRODUCTION OF AN ANTI-INFLAMMATORY SUBSTANCE AT A SITE OF INFLAMMATION.
    ROBINSON BV; ROBSON JM
    Br J Pharmacol Chemother; 1964 Oct; 23(2):420-32. PubMed ID: 14228142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phases of the inflammatory response to subcutaneous implantation of a cotton pellet and their modification by certain anti-inflammatory agents.
    Swingle KF; Shideman FE
    J Pharmacol Exp Ther; 1972 Oct; 183(1):226-34. PubMed ID: 4562620
    [No Abstract]   [Full Text] [Related]  

  • 9. BRL 20459, a novel topically active non-steroidal anti-inflammatory drug.
    Green AP; Mangan FR; Thomson MJ; Randall KE; Boyle EA
    J Pharm Pharmacol; 1984 May; 36(5):314-7. PubMed ID: 6145767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in functional ceruloplasmin concentrations of plasma and exudate and the effect of exogenous ceruloplasmin on the carrageenin-induced inflammation in rats.
    Nakagawa H; Suzuki K; Yamaki K; Tsurufuji S
    J Pharmacobiodyn; 1984 Oct; 7(10):755-9. PubMed ID: 6520697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of prostaglandin production in the inflammatory tissue by loxoprofen-Na, an anti-inflammatory prodrug.
    Sugimoto M; Kojima T; Asami M; Iizuka Y; Matsuda K
    Biochem Pharmacol; 1991 Nov; 42(12):2363-8. PubMed ID: 1764120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anti-inflammatory drugs on leucocyte migration and protein exudation into carboxymethylcellulose pouch in lathyritic rats.
    Ishikawa H; Mori Y; Niinobe S
    Chem Pharm Bull (Tokyo); 1969 Nov; 17(11):2279-84. PubMed ID: 5363290
    [No Abstract]   [Full Text] [Related]  

  • 13. Observations on the pharmacological properties of inflammatory exudate.
    Atkinson DC; Boura AL; Hicks R
    Eur J Pharmacol; 1969 Dec; 8(3):348-53. PubMed ID: 5370234
    [No Abstract]   [Full Text] [Related]  

  • 14. Proteinase inhibitors, kinins and the inflammatory reaction induced by sponge implantation in rats.
    Damas J; Bourdon V; Remacle-Volon G; Adam A
    Eur J Pharmacol; 1990 Jan; 175(3):341-6. PubMed ID: 1691101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anti-inflammatory drugs on urinary excretion of prostaglandin metabolites in cotton pellet inflammation.
    Yamada K; Aizawa Y
    Eur J Pharmacol; 1983 May; 90(1):91-5. PubMed ID: 6873179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa.
    Whittle BJ; Higgs GA; Eakins KE; Moncada S; Vane JR
    Nature; 1980 Mar; 284(5753):271-3. PubMed ID: 6767192
    [No Abstract]   [Full Text] [Related]  

  • 17. The evaluation of cotton twine as a new anti-inflammatory assay.
    Rassaert CL; Dipasquale G; O'Donoghue S
    Agents Actions; 1975 May; 5(2):128-32. PubMed ID: 1155301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction by dexamethasone of chemotactic activity in inflammatory exudates.
    Kurihara A; Ohuchi K; Tsurufuji S
    Eur J Pharmacol; 1984 May; 101(1-2):11-6. PubMed ID: 6745316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro effects of bromelain on PGE(2) and SP concentrations in the inflammatory exudate in rats.
    Gaspani L; Limiroli E; Ferrario P; Bianchi M
    Pharmacology; 2002 May; 65(2):83-6. PubMed ID: 11937778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical overview of nabumetone. Pharmacology, bioavailability, metabolism, and toxicology.
    Mangan FR; Flack JD; Jackson D
    Am J Med; 1987 Oct; 83(4B):6-10. PubMed ID: 3688000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.